CD4+CD25+ regulatory T cells generated in response to insulin B:9-23 peptide prevent adoptive transfer of diabetes by diabetogenic T cells - PubMed (original) (raw)
CD4+CD25+ regulatory T cells generated in response to insulin B:9-23 peptide prevent adoptive transfer of diabetes by diabetogenic T cells
Rinee Mukherjee et al. J Autoimmun. 2003 Nov.
Abstract
NOD mice have a relative deficiency of CD4+CD25+ regulatory T cells that could result in an inability to maintain peripheral tolerance. The aim of this study was to induce the generation of CD4+CD25+ regulatory T cells in response to autoantigens to prevent type 1 diabetes (T1D). We found that immunization of NOD mice with insulin B-chain peptide B:9-23 followed by 72 h in vitro culture with B:9-23 peptide induces generation of CD4+CD25+ regulatory T cells. Route of immunization has a critical role in the generation of these cells. Non-autoimmune mice BALB/c, C57BL/6 and NOR did not show up regulation of CD4+CD25+ regulatory T cells. These cells secreted large amounts of TGF-beta and TNF-alpha with little or no IFN-gamma and IL-10. Adoptive transfer of these CD4+CD25+ regulatory T cells into NOD-SCID mice completely prevented the adoptive transfer of disease by diabetogenic T cells. Although, non-self antigenic OVA (323-339) peptide immunization and in vitro culture with OVA (323-339) peptide does result in up regulation of CD4+CD25+ T cells, these cells did not prevent transfer of diabetes. Our study for the first time identified the generation of antigen-specific CD4+CD25+ regulatory T cells specifically in response to immunization with B:9-23 peptide in NOD mice that are capable of blocking adoptive transfer of diabetes. Our results suggest the possibility of using autoantigens to induce antigen-specific regulatory T cells to prevent and regulate autoimmune diabetes.
Similar articles
- Role of ICAM-1 and P-selectin expression in the development and effector function of CD4+CD25+regulatory T cells.
Kohm AP, Miller SD. Kohm AP, et al. J Autoimmun. 2003 Nov;21(3):261-71. doi: 10.1016/s0896-8411(03)00117-3. J Autoimmun. 2003. PMID: 14599851 - Nondepleting anti-CD4 monoclonal antibody prevents diabetes and blocks induction of insulin autoantibodies following insulin peptide B:9-23 immunization in the NOD mouse.
Liu E, Moriyama H, Paronen J, Abiru N, Miao D, Yu L, Taylor RM, Eisenbarth GS. Liu E, et al. J Autoimmun. 2003 Nov;21(3):213-9. doi: 10.1016/s0896-8411(03)00116-1. J Autoimmun. 2003. PMID: 14599846 - Perturbed homeostasis of peripheral T cells elicits decreased susceptibility to anti-CD3-induced apoptosis in prediabetic nonobese diabetic mice.
Yang W, Hussain S, Mi QS, Santamaria P, Delovitch TL. Yang W, et al. J Immunol. 2004 Oct 1;173(7):4407-16. doi: 10.4049/jimmunol.173.7.4407. J Immunol. 2004. PMID: 15383571 - CD3 antibody treatment stimulates the functional capability of regulatory T cells.
Chatenoud L. Chatenoud L. Novartis Found Symp. 2003;252:279-86; discussion 286-90. Novartis Found Symp. 2003. PMID: 14609225 Review. - Control of type 1 autoimmune diabetes by naturally occurring CD4+CD25+ regulatory T lymphocytes in neonatal NOD mice.
Piccirillo CA, Tritt M, Sgouroudis E, Albanese A, Pyzik M, Hay V. Piccirillo CA, et al. Ann N Y Acad Sci. 2005 Jun;1051:72-87. doi: 10.1196/annals.1361.048. Ann N Y Acad Sci. 2005. PMID: 16126946 Review.
Cited by
- Regulatory T cells in rheumatoid arthritis: functions, development, regulation, and therapeutic potential.
Yan S, Kotschenreuther K, Deng S, Kofler DM. Yan S, et al. Cell Mol Life Sci. 2022 Sep 29;79(10):533. doi: 10.1007/s00018-022-04563-0. Cell Mol Life Sci. 2022. PMID: 36173485 Free PMC article. Review. - High-performance multiplex drug-gated CAR circuits.
Li HS, Wong NM, Tague E, Ngo JT, Khalil AS, Wong WW. Li HS, et al. Cancer Cell. 2022 Nov 14;40(11):1294-1305.e4. doi: 10.1016/j.ccell.2022.08.008. Epub 2022 Sep 8. Cancer Cell. 2022. PMID: 36084652 Free PMC article. - Thymoquinone Preserves Pancreatic Islets Structure Through Upregulation of Pancreatic β-Catenin in Hypothyroid Rats.
Faddladdeen K, Ali SS, Bahshwan S, Ayuob N. Faddladdeen K, et al. Diabetes Metab Syndr Obes. 2021 Jun 29;14:2913-2924. doi: 10.2147/DMSO.S317417. eCollection 2021. Diabetes Metab Syndr Obes. 2021. PMID: 34234489 Free PMC article. - A Novel Liposome Formulation Carrying Both an Insulin Peptide and a Ligand for Invariant Natural Killer T Cells Induces Accumulation of Regulatory T Cells to Islets in Nonobese Diabetic Mice.
Akimoto H, Fukuda-Kawaguchi E, Duramad O, Ishii Y, Tanabe K. Akimoto H, et al. J Diabetes Res. 2019 Oct 23;2019:9430473. doi: 10.1155/2019/9430473. eCollection 2019. J Diabetes Res. 2019. PMID: 31781669 Free PMC article. - Early Growth Response Gene 2-Expressing CD4+LAG3+ Regulatory T Cells: The Therapeutic Potential for Treating Autoimmune Diseases.
Okamura T, Yamamoto K, Fujio K. Okamura T, et al. Front Immunol. 2018 Feb 26;9:340. doi: 10.3389/fimmu.2018.00340. eCollection 2018. Front Immunol. 2018. PMID: 29535721 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials